These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 922732)
1. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4). Matsuzawa A; Yamamoto T Cancer Res; 1977 Dec; 37(12):4408-15. PubMed ID: 922732 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4). Matsuzawa A; Mizuno Y; Yamamoto T Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771 [TBL] [Abstract][Full Text] [Related]
3. Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (10275-S). Matsuzawa A; Yamamoto T Cancer Res; 1976 May; 36(5):1598-606. PubMed ID: 178425 [TBL] [Abstract][Full Text] [Related]
4. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones. Matsuzawa A; Kaneko T; Ikeda Y Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of mepitiostane on the growth of mammary tumor of a rat. Takatani O; Kumaoka S Gan; 1977 Jun; 68(3):337-41. PubMed ID: 913955 [TBL] [Abstract][Full Text] [Related]
6. Response of a pregnancy-dependent mouse mammary tumor to hormones. Matsuzawa A; Yamamoto T J Natl Cancer Inst; 1975 Aug; 55(2):447-53. PubMed ID: 1159826 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines. Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949 [TBL] [Abstract][Full Text] [Related]
8. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors. Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624 [TBL] [Abstract][Full Text] [Related]
9. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice. Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284 [TBL] [Abstract][Full Text] [Related]
10. Enhanced and reversed growth in vitro of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by a gonadotropin-releasing hormone agonist analog. Matsuzawa A; Yamamoto T Eur J Cancer Clin Oncol; 1982 May; 18(5):495-505. PubMed ID: 6811279 [TBL] [Abstract][Full Text] [Related]
11. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents. Matsuzawa A; Ikeda Y Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137 [TBL] [Abstract][Full Text] [Related]
12. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320). Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525 [TBL] [Abstract][Full Text] [Related]
13. Pregnancy-dependent to ovarian-independent progression in mammary tumors delineated in primary culture: changes in signal transduction, growth factor regulation, and matrix interaction. Imagawa W; Bandyopadhyay GK; Garcia M; Matsuzawa A; Nandi S Cancer Res; 1992 Dec; 52(23):6531-8. PubMed ID: 1330295 [TBL] [Abstract][Full Text] [Related]
14. 2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid. Miyake T; Hori T; Kato G; Ide M; Uchida N; Yamaguchi K Steroids; 1974 Jun; 23(6):929-37. PubMed ID: 4836439 [No Abstract] [Full Text] [Related]
15. Effect of pregnancy, lactation, and pituitary isografts on the genesis of spontaneous mammary gland tumors in the mouse. Bruni JE; Montemurro DG Cancer Res; 1971 Dec; 31(12):1903-7. PubMed ID: 5120288 [No Abstract] [Full Text] [Related]
16. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors. Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083 [TBL] [Abstract][Full Text] [Related]
17. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats. Winneker RC; Parsons JA Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344 [TBL] [Abstract][Full Text] [Related]
18. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors. Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654 [TBL] [Abstract][Full Text] [Related]
19. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine. Yanai R; Nagasawa H J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649 [No Abstract] [Full Text] [Related]
20. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer. Cancer; 1978 Feb; 41(2):758-60. PubMed ID: 343913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]